Combining enzalutamide with abiraterone, prednisone, and androgen deprivation therapy in the STAMPEDE trial

Attard, G. et al. (2014) Combining enzalutamide with abiraterone, prednisone, and androgen deprivation therapy in the STAMPEDE trial. European Urology, 66(5), pp. 799-802. (doi: 10.1016/j.eururo.2014.05.038)

[img]
Preview
Text
100363.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

1MB

Publisher's URL: http://dx.doi.org/10.1016/j.eururo.2014.05.038

Abstract

No abstract available.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Russell, Dr Martin
Authors: Attard, G., Sydes, M. R., Mason, M. D., Clarke, N. W., Aebersold, D., de Bono, J. S., Dearnaley, D. P., Parker, C. C., Ritchie, A. W.S., Russell, J. M., Thalmann, G., Cassoly, E., Millman, R., Matheson, D., Schiavone, F., Spears, M. R., Parmar, M. K.B., and James, N. D.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:European Urology
Publisher:Elsevier
ISSN:0302-2838
ISSN (Online):1873-7560
Copyright Holders:Copyright © 2014 European Association of Urology
First Published:First published in European Urology 66(5):799-802
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record